Brief summary

Prospective, non-randomized, multi-center study assessing the long term safety and efficacy of the self expandable sirolimus eluting Xposition S stent in the treatment of unprotected left main coronary artery disease.

Primary endpoints

• Clinical Endpoint: Target Lesion Failure at 12 months post-procedure
• Efficacy Endpoint: Angiographic success at 12 months post-procedure: Achievement of <20% final residual stenosis at target lesion (visual estimation) with TIMI 3 flow in main branch.

CERC Services

• Project Management
• Electronic Data Capture Management
• Data Management
• Monitoring
• CEC activities
• Core Laboratory
• Safety Reporting
• Statistical Activities and Clinical Report

Countries

France, Germany, Italy, Poland, Switzerland and The Netherlands managed by CERC.

Center number

18 centers managed by CERC.